Abnormal Lipoprotein(a) Levels Predict Coronary Artery Calcification in Southeast Asians but Not in Caucasians: Use of Noninvasive Imaging for Evaluation of an Emerging Risk Factor

[1]  J. Borén,et al.  Lipoprotein(a) as a cardiovascular risk factor: current status , 2010, European heart journal.

[2]  Yujie Zhou,et al.  e0343 Triple versus dual antiplatelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention , 2010, Heart.

[3]  P. Joshi,et al.  Do We Know When and How to Lower Lipoprotein(a)? , 2010, Current treatment options in cardiovascular medicine.

[4]  R. Collins,et al.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.

[5]  J. Danesh,et al.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. , 2009, JAMA.

[6]  R. Kronmal,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[7]  M. Davidson.  Reducing residual risk for patients on statin therapy: the potential role of combination therapy. , 2005, The American journal of cardiology.

[8]  J. Manson,et al.  Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? , 2005, European heart journal.

[9]  Jonathan C. Cohen,et al.  Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study , 2005, Circulation.

[10]  D. Rajasekhar,et al.  Association of serum antioxidants and risk of coronary heart disease in South Indian population. , 2004, Indian journal of medical sciences.

[11]  E. Boerwinkle,et al.  Lack of association between lipoprotein(a) and coronary artery calcification in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. , 2004, Mayo Clinic proceedings.

[12]  L. M. Srivastava,et al.  Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease. , 2003, Atherosclerosis.

[13]  M. Boffa,et al.  Inhibition of Plasminogen Activation by Lipoprotein(a) , 2003, Journal of Biological Chemistry.

[14]  Nader Rifai,et al.  Handbook of Lipoprotein Testing , 2001 .

[15]  J. Danesh,et al.  Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.

[16]  G. Dangas,et al.  Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. , 1998, Journal of the American College of Cardiology.

[17]  J. Fallon,et al.  The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. , 1997, The Journal of clinical investigation.

[18]  P. Harpel,et al.  Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells. , 1997, Circulation.

[19]  H. Hobbs,et al.  The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans. , 1997, American journal of human genetics.

[20]  E. Wijsman,et al.  Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. , 1996, Journal of lipid research.

[21]  D. Sgoutas,et al.  Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells. , 1996, Atherosclerosis.

[22]  J. Rumberger,et al.  Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. , 1995, Circulation.

[23]  P. Weissberg,et al.  Proliferation of human smooth muscle cells promoted by lipoprotein(a). , 1993, Science.

[24]  A. Gown,et al.  Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia. , 1992, The American journal of pathology.

[25]  D. Rifkin,et al.  Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration , 1991, The Journal of cell biology.

[26]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[27]  J. Loscalzo,et al.  Lipoprotein(a), fibrin binding, and plasminogen activation. , 1990, Arteriosclerosis.

[28]  Manfred Dietel,et al.  Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries , 2005, Virchows Archiv A.

[29]  E. Janus,et al.  Frequency Distributions of Apolipoprotein(a) Kringle IV Repeat Alleles and Their Effects on Lipoprotein(a) Levels in Caucasian, Asian, and African Populations: The Distribution of Null Alleles Is Non-Random , 1996, European journal of human genetics : EJHG.

[30]  G. Lippi,et al.  Lipoprotein(a): Structure, Measurement and clinical significance. , 1994 .